LEO PHARMA INC recalls
Every recall we track for LEO PHARMA INC — 3 in all, from 2017–2026 — plus the complaints and injury reports the public filed about them.
Recalls per year, by danger level
3 recalls since 2017.
All FDA recall records for LEO PHARMA INC since 2017, counted by recall date (one bar per calendar year; 2026 is partial). Danger level is GovInfoNow’s plain-language rating; “not yet rated” records are still being written up.
| Year | Stop using now | Use caution | Lower risk | Not yet rated | Total |
|---|---|---|---|---|---|
| 2017 | 0 | 0 | 2 | 0 | 2 |
| 2018 | 0 | 0 | 0 | 0 | 0 |
| 2019 | 0 | 0 | 0 | 0 | 0 |
| 2020 | 0 | 0 | 0 | 0 | 0 |
| 2021 | 0 | 0 | 0 | 0 | 0 |
| 2022 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 0 | 0 | 0 |
| 2026 (to date) | 0 | 0 | 1 | 0 | 1 |
What to do if you have a recalled LEO PHARMA INC product
- Match the NDC and lot number on your bottle or box to the recall.
- Don’t stop a prescription on your own — ask your pharmacist or doctor for a replacement first.
- Report side effects to FDA MedWatch.
All LEO PHARMA INC recalls
3 shown- Lower riskDrug
LEO PHARMA INC recalls Adbry, (tralokinumab-ldrm) injection, 300 mg/2mL, Packaged as a) 1 x Single dose Autoinjector, SAMPLE NOT FOR SALE, NDC
LEO Pharma recalls Adbry (tralokinumab-ldrm) injections due to wool fiber contamination in one unit from a specific lot. This may cause infection if injected. Affected units have NDC codes 50222-350-91 or 50222-350-02.
LEO PharmaFeb 10, 2026 - Lower riskDrug
LEO PHARMA INC recalls Calcipotriene Cream 0.0005%, packaged in a) 60g tube, (NDC 66993-877-61), b) 120g tube (NDC 66993-877-78), Rx Only,
LEO Pharma recalls Calcipotriene Cream 0.0005% tubes due to missing drug excipient warnings and contact dermatitis risks in labeling. Affected products include 60g and 120g tubes with specific NDC numbers.
LEO PharmaJan 19, 2017 - Lower riskDrug
LEO PHARMA INC recalls Taclonex (calcipotriene and betamethasone dipropionate) Topical Suspension, 0.005%/0.064%, packaged in (a) 60 g (NDC
LEO Pharma recalls Taclonex topical suspension with outdated package insert (dated Feb 2014) to ensure proper usage instructions.
LEO PharmaJan 16, 2017
LEO PHARMA INC recall questions
How many recalls has LEO PHARMA INC had?
3 recalls from LEO PHARMA INC are on record with U.S. safety agencies, from 2017–2026.
What is the most recent LEO PHARMA INC recall?
LEO PHARMA INC recalls Adbry, (tralokinumab-ldrm) injection, 300 mg/2mL, Packaged as a) 1 x Single dose Autoinjector, SAMPLE NOT FOR SALE, NDC, dated Feb 10, 2026. Every LEO PHARMA INC recall is listed on this page, newest first.
What should I do if I have a recalled LEO PHARMA INC product?
Match the NDC and lot number on your bottle or box to the recall. Don’t stop a prescription on your own — ask your pharmacist or doctor for a replacement first. Report side effects to FDA MedWatch.
How do I get alerts for new LEO PHARMA INC recalls?
Sign up for free email alerts on GovInfoNow — we check official CPSC, FDA, USDA and NHTSA data every day and email you only when a recall matches what you follow.